AFX1, also known as Activating Transcription Factor X-1, is a transcription factor that plays a crucial role in regulating gene expression in response to various cellular stimuli. As a member of the ATF/CREB family of transcription factors, AFX1 binds to specific DNA sequences, known as cAMP response elements (CREs), within the promoter regions of target genes. Through its interaction with CREs, AFX1 modulates the transcription of genes involved in diverse cellular processes, including cell growth, differentiation, and apoptosis. Additionally, AFX1 has been implicated in the regulation of cellular responses to stress, such as oxidative stress and DNA damage, highlighting its importance in maintaining cellular homeostasis and survival.
Activation of AFX1 involves multiple interconnected signaling pathways that converge to regulate its transcriptional activity. One key mechanism of AFX1 activation is through the stimulation of cell surface receptors, such as receptor tyrosine kinases (RTKs) or G protein-coupled receptors (GPCRs), by extracellular ligands such as growth factors or hormones. Activation of these receptors triggers downstream signaling cascades, including the Ras/Raf/MEK/ERK pathway and the PI3K/Akt pathway, which ultimately lead to the phosphorylation and activation of AFX1. Additionally, AFX1 activity can be regulated by post-translational modifications, such as phosphorylation, acetylation, and sumoylation, which can modulate its DNA-binding affinity and transcriptional activity. Furthermore, AFX1 activity may be influenced by the cellular microenvironment, including changes in intracellular calcium levels, redox status, and nutrient availability. Overall, understanding the intricate mechanisms of AFX1 activation provides insights into its role in cellular physiology and its contribution to various physiological and pathological processes.
Items 1 to 10 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $60.00 $185.00 $365.00 | 64 | |
Activates AFX1 indirectly by modulating the SIRT1/AMPK pathway, leading to increased AFX1 activity through deacetylation and AMPK activation. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Stimulates adenylate cyclase, increasing cAMP levels, which activate PKA. PKA then indirectly activates AFX1 through phosphorylation. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Inhibits GSK-3, leading to reduced AFX1 phosphorylation and subsequent activation. | ||||||
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $108.00 $245.00 $918.00 $49.00 | 33 | |
Modulates PI3K/AKT signaling, indirectly activating AFX1 by enhancing its phosphorylation through the AKT pathway. | ||||||
Salidroside | 10338-51-9 | sc-472942 | 50 mg | $360.00 | 1 | |
Activates AFX1 by promoting AMPK phosphorylation, triggering downstream events that enhance AFX1 activity. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $80.00 $212.00 $408.00 | 48 | |
A selective inhibitor of the TGF-β type I receptor, indirectly influencing AFX1 by disrupting the TGF-β signaling pathway. | ||||||
Metformin | 657-24-9 | sc-507370 | 10 mg | $77.00 | 2 | |
Activates AFX1 through AMPK activation, which inhibits mTOR signaling and enhances AFX1 activity. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $182.00 $693.00 | 88 | |
Inhibits ROCK, influencing actin cytoskeleton dynamics and indirectly activating AFX1 through modulation of cellular tension. | ||||||
A-769662 | 844499-71-4 | sc-203790 sc-203790A sc-203790B sc-203790C sc-203790D | 10 mg 50 mg 100 mg 500 mg 1 g | $180.00 $726.00 $1055.00 $3350.00 $5200.00 | 23 | |
Activates AMPK, leading to increased AFX1 activity by enhancing AMPK-mediated phosphorylation events. | ||||||
Cisplatin | 15663-27-1 | sc-200896 sc-200896A | 100 mg 500 mg | $76.00 $216.00 | 101 | |
Indirectly activates AFX1 by inducing cellular stress and activating AMPK, triggering downstream events that enhance AFX1 activity. |